TERT-BUTYL (4R,5R)-5-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-2,2-DIMETHYL-4-(P-TOLYLSULFONYLOXYMETHYL)OXAZOLIDINE-3-CARBOXYLATE
UNII K2C6M37S5X
Substance Identification & Data
This profile provides standardized clinical and technical data for Tert-butyl (4r,5r)-5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,2-dimethyl-4-(p-tolylsulfonyloxymethyl)oxazolidine-3-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) K2C6M37S5X.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1972652-84-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H33NO8S HTNWJDMALLHETH-NFBKMPQASA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Tert-butyl (4r,5r)-5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,2-dimethyl-4-(p-tolylsulfonyloxymethyl)oxazolidine-3-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.